{"schema_version":"secwatch.filing_event.v1","accession":"0001297184-26-000038","form_type":"8-K","ticker":"AMPH","cik":"0001297184","company_name":"Amphastar Pharmaceuticals, Inc.","filed_at":"2026-06-03T20:15:45+00:00","discovered_at":"2026-06-03T20:17:00.237137+00:00","generated_at":"2026-06-03T20:45:34.109178+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Amphastar shareholders elect three directors, ratify EY, approve say-on-pay","bullets":["All three Class I nominees elected: Gaugh 35.2M for, Peters 23.6M for, Liawatidewi 23.2M for.","Peters and Liawatidewi each received over 11.7M against votes.","Ratification of Ernst & Young as auditor for FY2026 passed 39.2M to 0.7M.","Advisory say-on-pay approved 32.6M for; frequency set at 1 year with 33.8M votes.","All proposals passed with broker non-votes of 4.4M on director and advisory items."],"urls":{"canonical":"https://secwatch.observer/filing/0001297184-26-000038","json":"https://secwatch.observer/filing/0001297184-26-000038.json","markdown":"https://secwatch.observer/filing/0001297184-26-000038.md","text":"https://secwatch.observer/filing/0001297184-26-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/0001297184-26-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/amph-20260601x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T20:45:34.109178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06347adbc098788fde27d81ded9954e8bfa7b53c","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on compensation of named executive officers.","evidence_excerpt":"3. Advisory Vote on the Compensation of our Named Executive Officers ​ ​ For Against Abstained Broker Non-votes 32,585,908 2,779,281 111,803 4,439,978","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/0001297184-26-000038-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"1379277342ace57395448397e6da91d5f0aa1c73","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on frequency of future stockholder advisory votes on named executive officer compensation.","evidence_excerpt":"4. Advisory Vote on the Frequency of Future Stockholder Advisory Votes on Named Executive Officer Compensation ​ ​ ​ 1 Year 2 Years 3 Years Abstained Broker Non-votes 33,816,071 12,329 1,624,016 24,576 4,439,978","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/0001297184-26-000038-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"875a736f27806dc5ace08f7de3c4dbac31a8de9a","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Election of three Class I directors.","evidence_excerpt":"1. Election of Directors ​ ​ ​ ​ ​ ​ Nominee For Against Abstained Broker Non-votes David Gaugh 35,242,863 209,084 25,045 4,439,978 William J. Peters 23,652,131 11,785,772 39,089 4,439,978 Jacob Liawatidewi 23,224,791 12,212,988 39,213 4,439,978","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/0001297184-26-000038-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"88624184e0b976f0e3c8c1766c9ca555cba13e7c","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm.","evidence_excerpt":"2. Ratification of Appointment of Independent Registered Public Accounting Firm ​ ​ For Against Abstained Broker Non-votes 39,179,786 684,828 52,356 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000038/0001297184-26-000038-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}